Dr Bill Frankland: Penicillin, the pollen count and perspectives on medicine
Synapse - September 2019
par plusieurs auteurs
Webinar: Recent legislative developments affecting biologics and biosimilars
The Court of Justice on skinny labels
No compulsory licence for Sanofi's Praluent in Germany
SPC manufacturing waiver for export and stockpiling comes into force
Recent legislative developments affecting biologics and biosimilars
par plusieurs auteurs
Brexit update – 'Grandfathering' marketing authorisations
par Dr Paul England
Essentially biological processes and their products – what is patentable?
par Dr Paul England
Biosimilars webinar series – Recent developments in biosimilars settlements, market landscape and antitrust scrutiny
par plusieurs auteurs
Plausibility of second medical use patents: pregabalin in the Supreme Court
The grant of an SPC for a new therapeutic application